Kun Run Biotech Inc (KURU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KURU | IKT | ASRT | ||
| Company | Kun Run Biotech Inc | Inhibikase Therapeutics Inc | Assertio Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 4.9800 | 1.7400 | 19.58 | ||
| High | 4.9800 | 1.8300 | 20.22 | ||
| Low | 4.9800 | 1.7300 | 18.76 | ||
| Latest | 4.9800 | 1.8000 | 19.21 | ||
| Change | unch | -0.0100 | -0.67 | ||
| % Change | unch | -0.55% | -3.37% | ||
| Volume | 300 | 759,800 | 126,500 | ||
| 20-Day Average Volume | N/A | 1,690,025 | 153,255 | ||
| Previous Close | N/A | 1.8100 | 19.88 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 1.8140 | 14.95 | ||
| 20-Day Raw Stochastic | N/A | 46.94% | 86.72% | ||
| 20-Day Relative Strength | N/A | 50.64 | 72.86 | ||
| Weighted Alpha | N/A | -1.10 | +71.39 | ||
| Today's Opinion | N/A | 72% Buy | 100% Buy | ||
| Previous Opinion | N/A | 72% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/01/18 | +10.43% since 03/26/26 | -1.64% since 03/26/26 | ||
| Low | 4.9800 on 03/02/18 | 1.5700 on 03/30/26 | 17.92 on 03/30/26 | ||
| High | 4.9800 on 03/02/18 | 1.8300 on 04/02/26 | 20.22 on 04/02/26 | ||
| 1-Month | |||||
| %Chg | N/A since 03/01/18 | -6.74% since 03/02/26 | +63.21% since 03/02/26 | ||
| Low | 4.9800 on 03/02/18 | 1.5700 on 03/30/26 | 11.05 on 03/03/26 | ||
| High | 4.9800 on 03/02/18 | 2.0800 on 03/04/26 | 20.45 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | N/A since 03/01/18 | -7.69% since 01/02/26 | +110.18% since 01/02/26 | ||
| Low | 4.9800 on 03/02/18 | 1.4900 on 02/02/26 | 9.11 on 01/09/26 | ||
| High | 4.9800 on 03/02/18 | 2.2600 on 02/25/26 | 20.45 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | N/A since 03/01/18 | +9.76% since 10/02/25 | +40.24% since 10/02/25 | ||
| Low | 4.9800 on 03/02/18 | 1.3300 on 11/03/25 | 8.61 on 12/31/25 | ||
| High | 4.9800 on 03/02/18 | 2.2600 on 02/25/26 | 20.45 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 124,500 | 135,315 | 123,812 | ||
| Shares Outstanding, K | 25,000 | 75,175 | 6,445 | ||
| Annual Sales | 0 | 0 | 118,710,000 | ||
| Annual Net Income | 0 | -48,260,000 | -30,380,000 | ||
| Last Quarter Sales | N/A | 0 | 13,540,000 | ||
| Last Quarter Net Income | N/A | -12,730,000 | -11,930,000 | ||
| 60-Month Beta | 59.82 | 0.86 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.09 on 03/26/26 | -1.86 on 03/16/26 | ||
| Latest Earnings Date | 12/31/69 | 05/13/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||